Photo taken from The Leukemia and Lymphoma Society/X
Jul 13, 2024, 05:22
2024 Equity in Access Research Program Grantees of The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared on X:
“Let’s applaud our 2024 Equity in Access Research Program Grantees! We’ve awarded nearly $6.5M to address barriers to blood cancer treatment & care that may lead to better health outcomes – supported by Royalty Pharma & Astra Zeneca. Discover more about our grantees & their work.”
Aug 26, 2024, 06:10